Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic complexe : Œdème de Quincke héréditaire apparaissant durant la grossesse. | CMAJ | 2023 | 36649959 | PubTator, text mining | PubMed |
| Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine. | Elife | 2023 | 36648132 | PubTator, text mining | PubMed |
| CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients. | J Clin Transl Hepatol | 2023 | 36643051 | PubTator, text mining | PubMed |
| Proteomic profiling of urinary small extracellular vesicles in children with pneumonia: a pilot study. | Pediatr Res | 2023 | 36635400 | PubTator, text mining | PubMed |
| HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. | MAbs | 2023 | 36628468 | PubTator, text mining | PubMed |
| Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease. | BMC Genomics | 2023 | 36624378 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. | Adv Ther | 2023 | 36609679 | PubTator, text mining | PubMed |
| Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative. | World Allergy Organ J | 2023 | 36601261 | PubTator, text mining | PubMed |
| PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. | J Exp Clin Cancer Res | 2023 | 36588164 | PubTator, text mining | PubMed |
| Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses. | J Allergy Clin Immunol | 2023 | 36587848 | PubTator, text mining | PubMed |
| Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. | Haematologica | 2023 | 36519327 | PubTator, text mining | PubMed |
| Molecular modeling of C1-inhibitor as SARS-CoV-2 target identified from the immune signatures of multiple tissues: An integrated bioinformatics study. | Cell Biochem Funct | 2023 | 36517964 | PubTator, text mining | PubMed |
| Complement Inhibition in Kidney Transplantation: Where Are We Now? | BioDrugs | 2023 | 36512315 | PubTator, text mining | PubMed |
| A Case of Duodenal Edema-related Undiagnosed Hereditary Angioedema. | Intern Med | 2023 | 36418101 | PubTator, text mining | PubMed |
| A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia. | Intern Med | 2023 | 36418094 | PubTator, text mining | PubMed |
| Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system. | Immunol Rev | 2023 | 36398537 | PubTator, text mining | PubMed |
| Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function. | Immunol Res | 2023 | 36385678 | PubTator, text mining | PubMed |
| Recombinant mucin biotechnology and engineering. | Adv Drug Deliv Rev | 2023 | 36375719 | PubTator, text mining | PubMed |
| Kidney diseases. | Immunol Rev | 2023 | 36369988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=35